Memorial Sloan Kettering Cancer Center MSK Cardio-Oncology Symposium 2024
$70.00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Memorial Sloan Kettering Cancer Center MSK Cardio-Oncology Symposium 2024
- Include: 60 videos + 43 pdfs, size: 22.3 GB
- Target Audience: cardiologists, internists, hematologists/oncologists
- Sample video: contact me for sample video
Information:
Thursday, May 2, 2024, 8:00 AM – Friday, May 3, 2024, 6:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
The advances in cancer therapeutics has significantly improved cancer survival. With cancer mortality decreasing, cardiovascular disease has emerged as a formidable competing cause of death. Cancer survivors now demonstrate 2-5 times higher mortality risk due to cardiovascular disease than the general population, threatening to limit the gains achieved in cancer survival. In response to the growing concerns about the cardiovascular challenges faced by patients with cancer, the field of Cardio-Oncology has evolved, consisting of experts in both cancer and cardiovascular medicine working to improve the detection, monitoring, and treatment of cardiovascular disease at each stage of the cancer care continuum. The field is rapidly growing to meet the urgent need to improve the cardiovascular health of patients with cancer.
Join us in person in New York City for this state-of-the-art, comprehensive, case-based curriculum addressing critical topics relevant to the cardiovascular health of patients with cancer and cancer survivors. Together, an interdisciplinary group, consisting of cardiology and oncology experts from Memorial Sloan Kettering Cancer Center and around the world, will present the latest research and contemporary practice strategies in the prevention, early diagnosis, and management of cardiovascular disease in cancer patients and cancer survivors. The symposium will include a series of talks highlighting cutting-edge and trending subjects in the rapidly evolving field of Cardio-Oncology, ensuring that participants gain insights into the most recent advancements shaping the future of cardiovascular care for cancer patients.
This symposium will offer a forum for networking and professional collaboration. All presentations will include devoted time for interaction between audience members and presenters. Additionally, a complimentary networking reception will be held on Thursday, May 2, 2024, following the symposium, to provide an opportunity for the Cardio-Oncology community to interact and get to know each other. Please RSVP for the networking reception during registration. We hope to see you there!
Who Should Attend
This symposium is intended for cardiologists, internists, hematologists/oncologists, advanced practice providers, nurses, housestaff and other affiliated healthcare professionals who are involved in the care of cancer patients or have an interest in the field of cardio-oncology.
- Describe contemporary anti-cancer treatments (such as anthracyclines, targeted therapy, immunotherapy, cellular therapy, radiation), outlining their roles in cancer therapy, mechanisms of action, cardiotoxicity profiles, and their impact on the cardiovascular system
- Determine the strategies for monitoring and managing cardiotoxicity, identifying the evidence and the knowledge gaps
- Explain the diagnostic and treatment strategies for cardiac amyloidosis including advances in therapy
- Demonstrate the principles of the permissive cardiotoxicity strategy and how it applies in specific treatment scenarios
- Summarize the appropriate use of imaging modalities in contemporary Cardio-Oncology, from guidelines to best practices
- State the late cardiovascular sequelae of cancer treatment and the best approach to managing the cardiovascular health of adult survivors of childhood cancer
- Illustrate the challenges of managing acute cardiovascular disease in patients during cancer treatment
Topics:
- 2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..mp4
- 2022 ESC Cardio-Oncology Guidelines- Is There Evidence to Identify Who Is at High Risk..pdf
- 5FU Induced Chest Pain- Diagnostic and Management Algorithm.mp4
- 5FU Induced Chest Pain- Diagnostic and Management Algorithm.pdf
- A Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.mp4
- A Decade in Review- Top Research Studies and Clinical Trials in Cardio-Oncology.pdf
- Amyloidosis and Multiple Myeloma- Contemporary Diagnosis and New Advances in Treatment Q&A.mp4
- Atrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.mp4
- Atrial Fibrillation and Cancer- Pathophysiology and Management Algorithm.pdf
- Best Practices in the Management of Cardiovascular Disease in Patients with Cancer Q&A.mp4
- Breast Cancer- Best Practice Strategies to Optimize Outcomes Q&A.mp4
- Cancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.mp4
- Cancer Associated Non-Bacterial Thrombotic Endocarditis- Presentation, Pathophysiology, Management and Future Avenues.pdf
- Cancer Survivorship and Prevention Q&A.mp4
- Cancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..mp4
- Cancer Therapy-Related Cardiac Dysfunction and Heart Failure- Do the Traditional Paradigms Apply..pdf
- Cancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.mp4
- Cancer Therapy-Related HTN- Optimal Strategy to Achieve Effective BP Control.pdf
- Cancer-Associated Stroke- Etiology, Detection and Management.mp4
- Cancer-Associated Stroke- Etiology, Detection and Management.pdf
- Cardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.mp4
- Cardiac Amyloidosis- Unmasking the Great Masquerader – When to Suspect and How to Diagnose.pdf
- Cardio-Oncology- Moving the Field Forward Q&A.mp4
- CardioOnc2024_Brochure.pdf
- Cardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.mp4
- Cardiotoxicity Associated with Breast Cancer Treatment- Updates on Screening and Management.pdf
- Cardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.mp4
- Cardiovascular Challenges During and After Bone Marrow Transplant- How to Mitigate Adverse Cardiac Events and Optimize Cardiovascular Health.pdf
- Cardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.mp4
- Cardiovascular complications Associated with Lung Cancer Treatment- Screening, Diagnosis, and Management.pdf
- Cardiovascular Considerations in Hematologic Malignancies Q&A.mp4
- Cardiovascular Considerations of TKI Therapy in Chronic Leukemias.mp4
- Cardiovascular Considerations of TKI Therapy in Chronic Leukemias.pdf
- Cardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.mp4
- Cardiovascular Disease Burden in Patients with Cancer- Where and How Cardio-Oncology Can Make a Difference.pdf
- Cardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.mp4
- Cardiovascular Toxicity with Immune Checkpoint Inhibitors- Myocarditis and Beyond.pdf
- CART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.mp4
- CART T Cell Therapy- Navigating a New Frontier and Understanding the Cardiovascular Manifestations.pdf
- CASE PRESENTATION- ICI Myocarditis Cases from Mild to Deadly.mp4
- Common Risk Factors Between Cancer and Cardiovascular Disease.mp4
- Common Risk Factors Between Cancer and Cardiovascular Disease.pdf
- Contemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.mp4
- Contemporary Lung Cancer Diagnosis and Treatment- A Primer for the Non-Oncologist.pdf
- Contemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..mp4
- Contemporary Management of Prostate Cancer- Hormonal Therapy, Radiation, and Surgery – What Factors Influence Treatment Decisions..pdf
- Coronary Artery Disease in Cardio-Oncology Q&A.mp4
- Developing a Cancer Survivorship Health Care Model.mp4
- Electrophysiology in Cardio-Oncology Q&A.mp4
- Fundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.mp4
- Fundamentals of Antitumor Immunity and Current Applications in Solid Tumor Malignancy.pdf
- How I Use Strain and Biomarkers in My Practice.mp4
- How I Use Strain and Biomarkers in My Practice.pdf
- How to Manage Patients with Cardiac Implantable Devices During Radiation MRI.mp4
- How to Manage Patients with Cardiac Implantable Devices During Radiation MRI.pdf
- How to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.mp4
- How to Train in Cardio-Oncology- Cardio-Oncology Fellowship Programs.pdf
- IC-OS- Opportunities for Collaboration, Research, and Education.mp4
- IC-OS- Opportunities for Collaboration, Research, and Education.pdf
- Immunotherapy- Evolving Landscape in Diagnosing and Managing Immune Related Cardiotoxicity Q&A.mp4
- Implications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.mp4
- Implications of Cardiovascular Disease in Prostate Cancer Therapies- How to mitigate CV Risk During ADT.pdf
- Late Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.mp4
- Late Onset Cardiotoxicity in Adult Survivors of Childhood Cancer- Incidence, Risk Factors, and Individual Cardiovascular Risk Prediction.pdf
- Lung Cancer- Advances in Treatment and Their Impact on Cardiovascular Health.mp4
- Managing Patients with TTR Amyloidosis- Progress and Challenges.mp4
- Managing Patients with TTR Amyloidosis- Progress and Challenges.pdf
- Metabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..mp4
- Metabolic Issues in Cardio-Oncology- Can We Prevent Cancer by Improving Cardiovascular Risk Factors..pdf
- MR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.mp4
- MR Imaging of Cardiac Masses- Clinical Applications and Prognostic Implications.pdf
- Multimodality Imaging – Which Test, When, and Why..mp4
- Multimodality Imaging – Which Test, When, and Why..pdf
- Multiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.mp4
- Multiple Myeloma and AL amyloidosis- A Primer on Diagnosis and Management.pdf
- Navigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.mp4
- Navigating Cardiac Interventions in Patients with Active Cancer- Insights from Evidence and Experience.pdf
- Optimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.mp4
- Optimal Management of Patients with Acute Coronary Syndrome and Advanced Cancer.pdf
- Pharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..mp4
- Pharmacologic Cardioprotective Strategies to Prevent Cardiotoxicity. What Have We Learned from the Clinical Trials..pdf
- Prescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..mp4
- Prescribing Exercise to Mitigate Cardiovascular Toxicity in Clinical Practice- What are the Opportunities and Barriers..pdf
- Prevention in Cardio-Oncology Q&A.mp4
- Prostate Cancer and Cardiovascular Disease Q&A.mp4
- Racial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.mp4
- Racial and Ethnic Disparities in Cardio-Oncology Care- A Call to Action to Achieve Health Equity.pdf
- Radiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.mp4
- Radiation Induced Heart Disease- A Practical Guide to Diagnosis and Management.pdf
- Radiation Therapy and the Heart Q&A.mp4
- Radiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.mp4
- Radiation Therapy- Current and Future Strategies to Minimize Radiation Induced Cardiotoxicity.pdf
- Role of Imaging Markers and Biomarkers in Cardio-Oncology- Strategies for Early Detection of Cardiotoxicity. Q&A.mp4
- Striking the Balancing- Navigating Permissive Cardiotoxicity in Cancer Treatment.mp4
- The Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.mp4
- The Future of Clinical Trials- What I have learned Over 30+ Years as a Trialist.pdf
- Thrombosis and Hemostasis in Cancer Q&A.mp4
- Understanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why..pdf
- Understanding Stem Cell Bone Marrow Transplant- When, for Whom, and Why.mp4
- Updates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.mp4
- Updates in the Current Landscape of Contemporary Breast Cancer Treatment- Immunotherapy, HER2-targeted Therapy, and Antibody Drug Conjugates.pdf
- Venous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.mp4
- Venous Thromboembolism in Cancer Patients- Risk Assessment, Prevention and Treatment.pdf
Related products
INTERNAL MEDICINE BOOKS
PEPID Clinical Decision Support Account ( 1 year subscription, PC Only )
